Role of<i>PLB1</i>in Pulmonary Inflammation and Cryptococcal Eicosanoid Production
Mairi C. Noverr(Louisiana State University Health Sciences Center New Orleans), Gary B. Huffnagle(University of Michigan), John R. Perfect(Duke University), Gary M. Cox(Czech Academy of Sciences, Institute of Microbiology)
Cited by 136
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2010|2.7k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986
Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD
|PLoS ONE|2011|956